Beneficient (NASDAQ:BENF – Get Free Report) released its earnings results on Friday, August 14th. The company reported ($0.47) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.06) by $1.59, FiscalAI reports. The business had revenue of $15.93 million during the quarter, compared to the consensus estimate of $10.16 million.
Beneficient Price Performance
Shares of BENF stock opened at $0.54 on Wednesday. The stock has a market cap of $7.82 million, a P/E ratio of -0.08 and a beta of -0.04. The company has a fifty day moving average price of $2.33 and a two-hundred day moving average price of $3.10. Beneficient has a one year low of $0.50 and a one year high of $12.48.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Beneficient in a research note on Monday. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Beneficient currently has an average rating of “Sell”.
About Beneficient
Beneficient is a financial services company that provides liquidity solutions for holders of alternative assets. Its platform is designed to help investors access cash from otherwise illiquid investments, including interests in private equity, private credit, venture capital, real estate and other privately held assets.
The company offers trust-based liquidity and wealth-management solutions intended to simplify the process of monetizing alternative investments. Beneficient also provides related administrative, custody and fiduciary services through its technology-enabled platform, serving individual investors, trusts and other eligible asset holders.
Beneficient is headquartered in Dallas, Texas.
Read More
- Five stocks we like better than Beneficient
- AutoZone Shifts Gears, On Track to Reverse Course and Price Recovery
- Meta’s Muse Highlights Arm’s Growing Role in AI Infrastructure
- Oura’s $15.6 Billion IPO Is Betting Investors See More Than a Smart Ring
- AMD Chips Away at NVIDIA’s AI Throne
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.
